deferasirox
PolandDrugs containing this active substance
-
The medicine is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia and other types of anemia who have excess iron due to frequent blood transfusions or increased iron absorption from food.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg ATC: V03AC03
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.
-
The medicine is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia who have chronic iron overload due to frequent blood transfusions, as well as for patients with other types of anemia or transfusion-independent thalassemia syndromes.
Form: tablets, film-coated
Active substance Dosage deferasirox 180 mg ATC: V03AC03
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.
-
The medicine is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia who have chronic iron overload due to frequent blood transfusions, and for patients with other types of anemia or transfusion-independent thalassemia syndromes.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg ATC: V03AC03
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.
-
The medicine is used to remove excess iron from the body. It is intended for the treatment of chronic iron overload in patients with severe beta thalassemia, in patients with other types of anemia, and in individuals with transfusion-independent thalassemia syndromes.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg ATC: V03AC03
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
Exferana is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia who experience chronic iron overload due to frequent blood transfusions, and for patients with other types of anemia or thalassemia syndromes.
Form: tablets, film-coated
Active substance Dosage deferasirox 180 mg ATC: V03AC03
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used to remove excess iron from the body (iron overload). It is intended for patients with severe beta thalassemia who have chronic iron overload due to frequent blood transfusions, as well as for patients with other types of anemia or thalassemia syndromes.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg ATC: V03AC03
Manufacturer: Synthon B.V., Synthon Hispania S.L.